{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:59:08Z","timestamp":1791251948764,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.ucl.2006.06.012","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T09:28:46Z","timestamp":1168421326000},"page":"519-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Local Drug Delivery to Bladder Using Technology Innovations"],"prefix":"10.1016","volume":"33","author":[{"given":"Pradeep","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shachi","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leaf","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"de Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ucl.2006.06.012_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11934-002-0094-4","article-title":"Advances in drug delivery: improved bioavailability and drug effect","volume":"3","author":"Dmochowski","year":"2002","journal-title":"Curr Urol Rep"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.012_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.ju.0000150425.09317.67","article-title":"Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer\u2013Genito-Urinary\u00a0Group Phase III Trial (30906)","volume":"173","author":"de Reijke","year":"2005","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.012_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0094-0143(21)00993-9","article-title":"Practical uropharmacology","volume":"18","author":"Wein","year":"1991","journal-title":"Urol Clin North Am"},{"issue":"11","key":"10.1016\/j.ucl.2006.06.012_bib4","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1517\/14656566.5.11.2351","article-title":"Oxybutynin for treatment of urge urinary incontinence and overactive bladder: an updated review","volume":"5","author":"Abramov","year":"2004","journal-title":"Expert Opin Pharmacother"},{"issue":"3 Pt 1","key":"10.1016\/j.ucl.2006.06.012_bib5","first-page":"892","article-title":"Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism","volume":"160","author":"Buyse","year":"1998","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000019679","article-title":"Clinical response to an oral prostaglandin analogue in patients with interstitial cystitis","volume":"34","author":"Kelly","year":"1998","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-199937010-00004","article-title":"Intravesical drug delivery. Pharmacokinetic and clinical considerations","volume":"37","author":"Highley","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ucl.2006.06.012_bib8","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1136\/bmj.2.2239.1398","article-title":"The treatment of vesical papilloma by injections","volume":"2","author":"Herring","year":"1903","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ucl.2006.06.012_bib9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-5347(17)62954-9","article-title":"The use of dimethyl sulfoxide (DMSO) in the treatment of interstitial cystitis","volume":"98","author":"Stewart","year":"1967","journal-title":"J Urol"},{"issue":"5A Suppl","key":"10.1016\/j.ucl.2006.06.012_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0090-4295(97)00181-7","article-title":"Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis\u2014a practical approach","volume":"49","author":"Parkin","year":"1997","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.012_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0090-4295(78)90118-8","article-title":"Dimethyl sulfoxide in treatment of inflammatory genitourinary disorders","volume":"11","author":"Shirley","year":"1978","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.ucl.2006.06.012_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00042307-200409000-00005","article-title":"Second-line intravesical therapy versus cystectomy for bacille Calmette-Guerin\u00a0(BCG) failures","volume":"14","author":"Joudi","year":"2004","journal-title":"Curr Opin Urol"},{"issue":"6","key":"10.1016\/j.ucl.2006.06.012_bib13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1586\/14737140.4.6.1037","article-title":"Current state of immunotherapy for bladder cancer","volume":"4","author":"Kassouf","year":"2004","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.012_bib14","first-page":"269","article-title":"Bacillus Calmette-Guerin induces the expression of peroxisome proliferator-activated receptor gamma in bladder cancer cells","volume":"17","author":"Lodillinsky","year":"2006","journal-title":"Int J Mol Med"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.012_bib15","first-page":"65","article-title":"Targeting peroxisome proliferator-activated\u00a0receptors (PPARs) in kidney and urologic disease","volume":"54","author":"Guan","year":"2002","journal-title":"Minerva Urol Nefrol"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0090-4295(94)80284-X","article-title":"Bacillus Calmette-Guerin immunotherapy for refractory interstitial cystitis","volume":"43","author":"Zeidman","year":"1994","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.012_bib17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0094-0143(02)00055-1","article-title":"Current management of interstitial cystitis","volume":"29","author":"Lukban","year":"2002","journal-title":"Urol Clin North Am"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1464-410X.2004.04563.x","article-title":"Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity","volume":"93","author":"Hindley","year":"2004","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-5347(17)57034-2","article-title":"The urothelium: a battleground for oncogenesis","volume":"120","author":"Melicow","year":"1978","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.012_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1600-0854.2003.00156.x","article-title":"The uroepithelium: not just a passive barrier","volume":"5","author":"Apodaca","year":"2004","journal-title":"Traffic"},{"issue":"Pt 20","key":"10.1016\/j.ucl.2006.06.012_bib21","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1242\/jcs.00811","article-title":"Structural basis\u00a0of urothelial permeability barrier function as revealed by Cryo-EM studies of the 16 nm uroplakin particle","volume":"116","author":"Min","year":"2003","journal-title":"J Cell Sci"},{"issue":"5 Pt 1","key":"10.1016\/j.ucl.2006.06.012_bib22","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0022-5347(17)32495-3","article-title":"Identification of proteoglycans present at high density on bovine and human bladder luminal surface","volume":"152","author":"Hurst","year":"1994","journal-title":"J Urol"},{"issue":"7","key":"10.1016\/j.ucl.2006.06.012_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1078\/0171-9335-00326","article-title":"The maintenance of the permeability barrier of bladder facet cells requires a continuous fusion of discoid vesicles with the apical plasma membrane","volume":"82","author":"Born","year":"2003","journal-title":"Eur J Cell Biol"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.012_bib24","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1128\/iai.24.2.552-557.1979","article-title":"Antibacterial activity of bladder surface mucin duplicated by exogenous glycosaminoglycan (heparin)","volume":"24","author":"Parsons","year":"1979","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib25","first-page":"139","article-title":"Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine","volume":"4","author":"Gao","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.ucl.2006.06.012_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/93.8.597","article-title":"Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial","volume":"93","author":"Au","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"1\u20133","key":"10.1016\/j.ucl.2006.06.012_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-3659(01)00488-6","article-title":"Clinical aspects of drug delivery to tumors","volume":"78","author":"Au","year":"2002","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.ucl.2006.06.012_bib28","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/01.ju.0000148361.82074.77","article-title":"Abnormal urinary potassium metabolism in patients with interstitial cystitis","volume":"173","author":"Parsons","year":"2005","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/039463200501800119","article-title":"A pilot open label study of Cystoprotek(R) in interstitial cystitis","volume":"18","author":"Theoharides","year":"2005","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.012_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.eururo.2004.10.022","article-title":"Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis?","volume":"47","author":"Daha","year":"2005","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.012_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1517\/14656566.5.2.287","article-title":"Current strategies for managing interstitial cystitis","volume":"5","author":"Parsons","year":"2004","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2490-5-4","article-title":"Exogenous glycosaminoglycans coat damaged bladder surfaces in experimentally damaged mouse bladder","volume":"5","author":"Kyker","year":"2005","journal-title":"BMC Urol"},{"issue":"3 Suppl 1","key":"10.1016\/j.ucl.2006.06.012_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.urology.2003.10.034","article-title":"Treatment of interstitial cystitis","volume":"63","author":"Chancellor","year":"2004","journal-title":"Urology"},{"issue":"3 Suppl 1","key":"10.1016\/j.ucl.2006.06.012_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.urology.2003.11.001","article-title":"Mechanisms involved in new therapies for overactive bladder","volume":"63","author":"Cruz","year":"2004","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cne.903180108","article-title":"Age-related changes in capsaicin-induced degeneration in rat brain","volume":"318","author":"Ritter","year":"1992","journal-title":"J Comp Neurol"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.012_bib36","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1124\/jpet.103.064162","article-title":"Ethanol causes inflammation in the airways by a neurogenic and TRPV1-dependent mechanism","volume":"309","author":"Trevisani","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.ju.0000100385.93801.d4","article-title":"Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study","volume":"171","author":"de Seze","year":"2004","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/01.ju.0000102360.11785.d7","article-title":"Urodynamic and immunohistochemical evaluation of intravesical capsaicin delivery using thermosensitive hydrogel and liposomes","volume":"171","author":"Tyagi","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2006.06.012_bib39","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/1921197a0","article-title":"A correlation between surface charge and coagulant action of phospholipids","volume":"192","author":"Bangham","year":"1961","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ucl.2006.06.012_bib40","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/S0022-5347(01)64822-5","article-title":"Liposome encapsulated doxorubicin transfer to the pelvic lymph nodes by endoscopic administration into the bladder wall: a preliminary report","volume":"157","author":"Tsuruta","year":"1997","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.ucl.2006.06.012_bib41","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1442-2042.2004.00855.x","article-title":"Antitumor effect of simultaneous transfer of interleukin-12 and interleukin-18 genes and its mechanism in a mouse bladder cancer model","volume":"11","author":"Hikosaka","year":"2004","journal-title":"Int J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2006.06.012_bib42","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1172\/JCI23043","article-title":"Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer","volume":"115","author":"Nogawa","year":"2005","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.ucl.2006.06.012_bib43","first-page":"713","article-title":"Non-viral tumor necrosis factor-alpha gene transfer decreases the incidence of orthotopic bladder tumors","volume":"14","author":"Zang","year":"2004","journal-title":"Int J Mol Med"},{"issue":"18","key":"10.1016\/j.ucl.2006.06.012_bib44","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/jnci\/81.18.1387","article-title":"Augmentation of antiproliferative activity of interferon alfa against human bladder tumor cell lines by encapsulation of interferon alfa within liposomes","volume":"81","author":"Killion","year":"1989","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.ucl.2006.06.012_bib45","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0022-5347(17)40248-5","article-title":"The development of liposomes containing interferon alpha for the intravesical therapy of human superficial bladder cancer","volume":"143","author":"Frangos","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2006.06.012_bib46","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0076-6879(05)91017-3","article-title":"Liposomal polyene antibiotics","volume":"391","author":"Ng","year":"2005","journal-title":"Methods Enzymol"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.012_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-1838(90)90256-I","article-title":"Effect of urethane anesthesia on the micturition reflex in capsaicin-treated rats","volume":"30","author":"Maggi","year":"1990","journal-title":"J\u00a0Auton Nerv Syst"},{"issue":"Suppl 2","key":"10.1016\/j.ucl.2006.06.012_bib48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000246039","article-title":"Povidone-iodine liposomes\u2014an overview","volume":"195","author":"Reimer","year":"1997","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.012_bib49","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0090-4295(02)02281-1","article-title":"Intravesical liposome administration\u2014a novel treatment for hyperactive bladder in the rat","volume":"61","author":"Fraser","year":"2003","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/nau.1930120106","article-title":"Urothelial permeability of the isolated whole bladder","volume":"12","author":"Tammela","year":"1993","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.012_bib51","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1517\/17425247.2.3.533","article-title":"Emerging strategies for the transdermal delivery of peptide and protein drugs","volume":"2","author":"Schuetz","year":"2005","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"10.1016\/j.ucl.2006.06.012_bib52","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/archopht.1949.00900050424007","article-title":"Influence of iontophoresis on the permeability of the excised cornea","volume":"42","author":"Dyson","year":"1949","journal-title":"Arch Ophthal"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.012_bib53","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0022-5347(01)61929-3","article-title":"Electromotive drug administration of lidocaine as an alternative anesthesia for transurethral surgery","volume":"161","author":"Jewett","year":"1999","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.012_bib54","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1464-410X.1997.32419.x","article-title":"Bladder and urethral anaesthesia with electromotive drug administration (EMDA): a technique for invasive endoscopic procedures","volume":"79","author":"Fontanella","year":"1997","journal-title":"Br J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1470-2045(05)70472-1","article-title":"Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial","volume":"7","author":"Di Stasi","year":"2006","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.012_bib56","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/nau.10157","article-title":"Transient ischemic attack after electromotive drug administration for chronic non-infectious cystitis: report of two similar cases","volume":"23","author":"Hinkel","year":"2004","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.012_bib57","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/sj.cgt.7700658","article-title":"Treatment of bladder carcinomas using recombinant BCG DNA vaccines and electroporative gene immunotherapy","volume":"11","author":"Lee","year":"2004","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000052419","article-title":"Thermo-chemotherapy and electromotive drug administration of mitomycin C in superficial bladder cancer eradication. a pilot study on marker lesion","volume":"39","author":"Colombo","year":"2001","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib59","first-page":"363","article-title":"Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel","volume":"9","author":"Chen","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.012_bib60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00299723","article-title":"Dimethylsulfoxide enhances the absorption of chemotherapeutic drug instilled into the bladder","volume":"20","author":"Hashimoto","year":"1992","journal-title":"Urol Res"},{"issue":"9","key":"10.1016\/j.ucl.2006.06.012_bib61","first-page":"1353","article-title":"[Studies on enhancement of drug absorption through the bladder mucosa]","volume":"85","author":"Sasaki","year":"1994","journal-title":"Nippon Hinyokika Gakkai Zasshi"},{"issue":"6","key":"10.1016\/j.ucl.2006.06.012_bib62","first-page":"833","article-title":"[Postoperative intravesical installation of tetrahydropyranyl-adriamycin (THP) and cytosine arabinoside (CA) for superficial bladder cancer: clinical results of prophylactic effects on recurrence]","volume":"21","author":"Hashimoto","year":"1994","journal-title":"Gan To Kagaku Ryoho"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.012_bib63","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.ju.0000175099.01082.d0","article-title":"Urgency, botulinum toxin and how botulinum toxin can help urgency","volume":"174","author":"Chancellor","year":"2005","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.012_bib64","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.ju.0000143189.19835.f3","article-title":"Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation","volume":"173","author":"Vemulakonda","year":"2005","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib65","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.urology.2005.01.055","article-title":"In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats","volume":"66","author":"Khera","year":"2005","journal-title":"Urology"},{"issue":"4 Pt 1","key":"10.1016\/j.ucl.2006.06.012_bib66","doi-asserted-by":"crossref","first-page":"C1013","DOI":"10.1152\/ajpcell.1994.267.4.C1013","article-title":"Mammalian urinary bladder permeability is altered by cationic proteins: modulation by divalent cations","volume":"267","author":"Tzan","year":"1994","journal-title":"Am J Physiol"},{"issue":"5433","key":"10.1016\/j.ucl.2006.06.012_bib67","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ucl.2006.06.012_bib68","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1023\/A:1016136328329","article-title":"Conjugates of antisense oligonucleotides with the TAT and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions","volume":"19","author":"Astriab-Fisher","year":"2002","journal-title":"Pharm Res"},{"key":"10.1016\/j.ucl.2006.06.012_bib69","first-page":"343","article-title":"Gene targeting using peptide nucleic acid","volume":"288","author":"Nielsen","year":"2005","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.ucl.2006.06.012_bib70","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1389-0344(01)00075-2","article-title":"PNA oligomers as tools for specific modulation of gene expression","volume":"17","author":"Pooga","year":"2001","journal-title":"Biomol Eng"},{"issue":"4","key":"10.1016\/j.ucl.2006.06.012_bib71","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1021\/mp050093x","article-title":"Intravesical antisense therapy for cystitis using TAT-peptide nucleic acid conjugates","volume":"3","author":"Tyagi","year":"2006","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib72","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0302-2838(03)00418-4","article-title":"Intravesical infusion of resiniferatoxin by a temporary in situ drug delivery system to treat interstitial cystitis: a pilot\u00a0study","volume":"45","author":"Lazzeri","year":"2004","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ucl.2006.06.012_bib73","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/106002809402800508","article-title":"Treatment of\u00a0cyclophosphamide-induced hemorrhagic cystitis with prostaglandins","volume":"28","author":"Miller","year":"1994","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib74","first-page":"155","article-title":"[Bladder irrigation with prostaglandin E2 in cyclophosphamide-induced hemorrhagic cystitis]","volume":"15","author":"Saito","year":"1988","journal-title":"Gan To Kagaku Ryoho"},{"issue":"6","key":"10.1016\/j.ucl.2006.06.012_bib75","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0090-4295(99)80349-5","article-title":"Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation","volume":"46","author":"Ippoliti","year":"1995","journal-title":"Urology"},{"issue":"1\u20132","key":"10.1016\/j.ucl.2006.06.012_bib76","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0168-3659(99)00194-7","article-title":"Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers","volume":"63","author":"Jeong","year":"2000","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.ucl.2006.06.012_bib77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1097-4636(199601)30:1<31::AID-JBM5>3.0.CO;2-S","article-title":"In vivo biocompatibility study of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks","volume":"30","author":"Ronneberger","year":"1996","journal-title":"J Biomed Mater Res"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.012_bib78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F","article-title":"In situ gelation of PEG-PLGA-PEG triblock copolymer aqueous solutions and degradation thereof","volume":"50","author":"Jeong","year":"2000","journal-title":"J Biomed Mater Res"},{"issue":"5","key":"10.1016\/j.ucl.2006.06.012_bib79","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1023\/B:PHAM.0000026436.62869.9c","article-title":"Sustained intravesical drug delivery using thermosensitive hydrogel","volume":"21","author":"Tyagi","year":"2004","journal-title":"Pharm Res"},{"issue":"4444","key":"10.1016\/j.ucl.2006.06.012_bib80","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1126\/science.6154316","article-title":"Bladder-surface glycosaminoglycans: an efficient mechanism of environmental adaptation","volume":"208","author":"Parsons","year":"1980","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.012_bib81","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0168-3659(00)00303-5","article-title":"Mucoadhesive drug carriers based on complexes of poly(acrylic acid) and PEGylated drugs having hydrolysable PEG-anhydride-drug linkages","volume":"69","author":"Lele","year":"2000","journal-title":"J Control Release"},{"issue":"8","key":"10.1016\/j.ucl.2006.06.012_bib82","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.2042-7158.1997.tb06103.x","article-title":"Bioadhesive microspheres for ophthalmic administration of acyclovir","volume":"49","author":"Genta","year":"1997","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.012_bib83","first-page":"1324","article-title":"Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer","volume":"171","author":"Le Visage","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"1\u20132","key":"10.1016\/j.ucl.2006.06.012_bib84","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-5173(03)00074-7","article-title":"Influence of chitosan and polycarbophil on permeation of a model hydrophilic drug into the urinary bladder wall","volume":"256","author":"Grabnar","year":"2003","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.012_bib85","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1517\/14712598.2.3.287","article-title":"Developments in the area of bioadhesive drug delivery systems","volume":"2","author":"Haas","year":"2002","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.ucl.2006.06.012_bib86","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-0-306-48584-8_18","article-title":"Bioadhesive drug carriers for postoperative chemotherapy in bladder cancer","volume":"553","author":"Ozturk","year":"2004","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"10.1016\/j.ucl.2006.06.012_bib87","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nm0597-571","article-title":"Urinary bladder-urethral sphincter dysfunction in mice with targeted disruption of neuronal nitric oxide synthase models idiopathic voiding disorders in humans","volume":"3","author":"Burnett","year":"1997","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ucl.2006.06.012_bib88","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00001813-199607000-00002","article-title":"Drug retention following intravesical delivery of fluorouracil therapeutic adhesive in C3H mouse bladder","volume":"7","author":"Singh","year":"1996","journal-title":"Anticancer Drugs"},{"issue":"3","key":"10.1016\/j.ucl.2006.06.012_bib89","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/mrm.20395","article-title":"MR imaging of biodegradable polymeric microparticles: a potential method of monitoring local drug delivery","volume":"53","author":"Chen","year":"2005","journal-title":"Magn Reson Med"},{"issue":"6","key":"10.1016\/j.ucl.2006.06.012_bib90","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00280-003-0597-9","article-title":"Intravesical administration of doxorubicin to swine bladder using magnetically targeted carriers","volume":"51","author":"Leakakos","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.1016\/j.ucl.2006.06.012_bib91","first-page":"145","article-title":"Novel gelatin-adriamycin sustained drug release system for intravesical therapy of bladder cancer","volume":"21","author":"Ye","year":"2001","journal-title":"J Tongji Med Univ"},{"issue":"8","key":"10.1016\/j.ucl.2006.06.012_bib92","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1442-2042.2004.00871.x","article-title":"Urodynamic effects and safety of modified intravesical oxybutynin chloride in patients with neurogenic detrusor overactivity: 3 years experience","volume":"11","author":"Saito","year":"2004","journal-title":"Int J Urol"},{"issue":"22","key":"10.1016\/j.ucl.2006.06.012_bib93","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1158\/1078-0432.CCR-04-1443","article-title":"Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy","volume":"10","author":"Lu","year":"2004","journal-title":"Clin Cancer Res"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014306000723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014306000723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:19:31Z","timestamp":1758806371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014306000723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0094014306000723"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2006.06.012","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local Drug Delivery to Bladder Using Technology Innovations","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2006.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}